Available from: Margis, R., Dunand, C., Teixeira, F
According to Centers for Medicare & Medicaid Services (CMS) standards, even intensive behavioral treatment for obesity requires reassessment at the six-month mark, with continued therapy contingent upon achieving at least 3kg weight reduction
In the UK, the MHRA approves licences and reviews invented names to minimise medication errors
This guide explains the major classes of diabetes medication, what current NICE and ADA guidelines recommend, and what to expect from each: including side effects, monitoring, and the situations where one class is preferred over another
WHO-GMP Compliance Leading manufacturers strictly follow WHO-GMP (World Health Organization Good Manufacturing Practices) guidelines
In many cases, doctors have been prescribing Ozempic and Mounjaro 'off label' to people looking to lose weight but who do not have type 2 diabetes which is what they were initially intended to treat contributing to shortages